rs2074888
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003200.5(TCF3):c.1475C>T(p.Ala492Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0241 in 1,574,730 control chromosomes in the GnomAD database, including 4,192 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003200.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TCF3 | NM_003200.5 | c.1475C>T | p.Ala492Val | missense_variant | 17/19 | ENST00000262965.12 | NP_003191.1 | |
TCF3 | NM_001136139.4 | c.1475C>T | p.Ala492Val | missense_variant | 17/20 | ENST00000588136.7 | NP_001129611.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCF3 | ENST00000262965.12 | c.1475C>T | p.Ala492Val | missense_variant | 17/19 | 1 | NM_003200.5 | ENSP00000262965.5 | ||
TCF3 | ENST00000588136.7 | c.1475C>T | p.Ala492Val | missense_variant | 17/20 | 2 | NM_001136139.4 | ENSP00000468487.1 |
Frequencies
GnomAD3 genomes AF: 0.0346 AC: 5256AN: 152030Hom.: 503 Cov.: 32
GnomAD3 exomes AF: 0.0594 AC: 13197AN: 222056Hom.: 1736 AF XY: 0.0571 AC XY: 6718AN XY: 117754
GnomAD4 exome AF: 0.0230 AC: 32660AN: 1422582Hom.: 3691 Cov.: 37 AF XY: 0.0239 AC XY: 16746AN XY: 701578
GnomAD4 genome AF: 0.0345 AC: 5250AN: 152148Hom.: 501 Cov.: 32 AF XY: 0.0389 AC XY: 2890AN XY: 74378
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Myeloproliferative neoplasm, unclassifiable Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Dept. of Cytogenetics, ICMR- National Institute of Immunohaematology | Aug 25, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at